An Enabling Technology for a Range of Applications
Our platform utilizes a novel, disruptive bio-detection technology using silicon biochips with embedded waveguides. Laser light injected into nano-scale waveguides produces detection that occurs at the intersection of two perpendicular sets of waveguides emitting the wavelength-shifted fluorescence and enabling the interrogation of specific sensing areas for the detection of up to 32 targets (i.e., biomarkers).
The Q-SENS Point-of-Need solution offers:
Results are instantly uploaded to a cloud server, allowing AI and ML algorithms to deliver increasingly nuanced and personalized insights.
Our platform, protected by 20 patents, has demonstrated exceptional performance on ~50 different assays (immunoassays and molecular) and is ready to be commercialized. We are working along with our dedicated partners to bring our solutions to the market.